Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
HRS 25: The BIO-LIBRA Study
Author(s): Valentina Kutyifa Added: 9 months ago
HRS 2025 - Contemporary outcomes from implantable devices in non-ischemic cardiomyopathy patients observed more advanced heart failure symptoms in women at the time of ICD implantation, and white women implanted with CRT-D devices had significantly lower ventricular arrhythmia events compared to men of all races and black women implanted with both device types.Dr Valentina Kutyifa (University of… View more

Demographic

Electrophysiology & Arrhythmia
LB-NICM: New Approach
Author(s): Shunmuga Sundaram Ponnusamy , Pugazhendhi Vijayaraman , Kenneth Ellenbogen Added: 1 year ago

Heart Failure

Electrophysiology & Arrhythmia
Arrhythmogenic Cardiomyopathy with Prof Elena Arbelo
Author(s): Elena Arbelo Added: 2 months ago
Understand the evolving landscape of arrhythmogenic cardiomyopathy (ACM) risk stratification and ICD decision-making with Prof Elena ArbeloThis presentation, part of the comprehensive Cardiomyopathies track, explores the critical shift from phenotype-based to genotype-informed risk assessment in arrhythmogenic cardiomyopathy management, addressing the significant challenge that over half of… View more

Electrophysiology & Arrhythmia

Imaging & Diagnostics
Functional Substrate Mapping
Author(s): Jaffar Al-Sheikhli , Patrick Tran , Rafaella Siang , et al Added: 1 year ago

Electrophysiology & Arrhythmia
Ablation vs Drugs for VT: Insights from VANISH2
Added: 3 weeks ago Source:  Radcliffe Cardiology
A prespecified substudy of the VANISH2 trial suggests first-line catheter ablation is superior to sotalol for reducing arrhythmia events in eligible patients with ischaemic cardiomyopathy and ventricular tachycardia (VT).¹ In patients ineligible for sotalol, ablation showed comparable efficacy to amiodarone but with a markedly better long-term safety profile.MethodologyThe VANISH2 (Ventricular… View more

Electrophysiology & Arrhythmia

Heart Failure
Federico M Asch
Research Area(s) / Expertise: Job title: Director of the Echocardiography Core Lab at MedStar Health Research Institute and Associate Professor of Medicine
Dr Federico Asch is the Director of the Echocardiography Core Lab at MedStar Health Research Institute and Associate Professor of Medicine (Cardiology) at Georgetown University. His research interests are: Myocardial viability in Ischemic Cardiomyopathy, Devices in Cardiovascular Diseases, Role of Echocardiography in clinical trials, and Contrast Echocardiography.a View more
Ventricular Tachycardia Ablation: Meta-analysis of Randomised Trials
Author(s): Rohin K Reddy , James P Howard , Yousif Ahmad , et al Added: 2 years ago

Electrophysiology & Arrhythmia
Ventricular Tachycardia After Cardioversion
Author(s): Eiad Habib , Mahmoud Abdelnabi , Ramzi Ibrahim , et al Added: 2 months ago

Electrophysiology & Arrhythmia

Heart Failure
Job title: Staff Cardiac Surgeon at the Department of Cardiac Surgery
European Heart Rhythm Association (EHRA) Congress 2024 Reveals its Late-Breaking Clinical Trial Presentations for 2024
Added: 1 year ago Source:  EHRA 2024
The European Heart Rhythm Association (EHRA) Congress has announced four late-breaking clinical trial sessions to be presented in April.EHRA 24 will take place in Berlin and online from the 7th to the 9th April 2024. Access the full programme here.For short, concise coverage of the key data revealed, check out our video collection with Expert Interviews and Highlights, focussing on the results,… View more